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H-deficient Bombay and para-
Bombay red blood cells are most
strongly agglutinated by the
galactophilic lectins of Aplysia
and Pseudomonas aeruginosa
that detect I and P1 antigens
N. GILBOA-GARBER, D. SUDAKEVITZ, C. LEVENE, N. RAHIMI-LEVENE, AND V. YAHALOM
The galactophilic lectins Aplysia gonad lectin (AGL) and
Pseudomonas aeruginosa lectin (PA-IL),which detect human I and
P1 RBC antigens, were examined for hemagglutination of H+
(group O and B) and H-deficient (Bombay and para-Bombay
phenotype) RBCs. The results were compared with those obtained
using two other galactophilic lectins, Maclura pomifera lectin
(MPL) and Arachis hypogaea (peanut) agglutinin (PNA), which
share T-antigen affinity, and two fucose-binding H-specific lectins,
Ulex europaeus (UEA-I) and Pseudomonas aeruginosa lectin (PA-
IIL), as well as with those achieved with anti-I serum. The results
revealed that, in contrast to UEA-I and PA-IIL, which preferentially
agglutinated H+ RBCs, and to MPL and PNA, which similarly
agglutinated all examined RBCs, AGL, PA-IL, and the anti-I serum
agglutinated the H-deficient RBCs more strongly than did the H+
RBCs. These findings could be attributed to increased levels of I
and P1 antigens on those RBCs resulting from the use of the free
common H-type 2 precursor for their synthesis. Since both PA-IL
and PA-IIL are regarded as potential pathogen adhesins, it would be
interesting to statistically compare the sensitivities of individuals of
H+ and H-deficient RBC populations to P. aeruginosa infections.
Immunohematology 2006;22:15–22.
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Lectins, by virtue of their selective carbohydrate-
binding capability, are powerful tools for use in the
investigation of human RBC membrane antigenic lipid-
and protein-associated glycans. In addition to their past
crucial contribution to the disclosure of blood group
antigen structures,1–4 lectins displaying blood group
specificities are important for blood group
identification and for antigen typing.5–7 Several lectins
are widely used in blood banks: Ulex europaeus lectin
(UEA-I) as an anti-H8 and as an aid in determining
“secretor” status, replacing anti-H sera from individuals
of the rare Bombay phenotype9; Arachis hypogaea
(peanut) agglutinin (PNA) as anti-T10; Helix pomatia
and Dolichos biflorus lectins for determining A
subgroups11; and Salvia horminum and Salvia sclarea
as anti-Tn lectins.12 It is important to note that multiple
lectins with differing specificities can be obtained from
the same organism. Examples of this include the series
of U. europaeus (UEA-I and UEA-II) and Griffonia
simplicifolia lectins. An advantage of lectins, in
addition to their use in determining unique blood
group antigen specificities and providing additional
biochemical information as to the composition of
antigen glycotopes, is their resistance to denaturation,
enabling long-term use of their standardized stocks.
Lectin panels are generally used to obtain more
detailed information on human RBC antigens and to
elucidate sugar variations associated with antigen
depletion or modification. Such changes may occur
due to genetic mutations, diverse disease states (e.g.,
infections, cancer13), and developmental processes.14
For example, the unmasking of RBC subterminal
galactose (Gal) by desialylation is demonstrated by T
antigen–detecting lectins, including PNA10 and
Maclura pomifera lectin (MPL).15 Lectins can also
assist in the study of biochemical pathways leading to
diverse antigen formation (Fig. 1) subsequent to
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consecutive sequential degradation of their
oligosaccharide moieties.
In the present study, four galactophilic lectins and
anti-I serum were used together with two L-fucose
binding lectins for the study of variations associated
with H-antigen deficiency in RBCs from individuals of
Bombay and para-Bombay phenotypes. The galacto-
philic lectins used in this study were an animal lectin,
Aplysia gonad lectin (AGL),16,17 isolated from the giant
marine snail; a bacterial lectin of the opportunistic
pathogen P. aeruginosa (PA-IL)18–20; and the previously
described plant seed lectins MPL15 and PNA.10 The
fucose-binding lectins included the plant seed lectin
UEA-I8 and the second lectin of P. aeruginosa, PA-
IIL.20–23 The hemagglutinating activities of these lectins
(listed in Table 1) and the anti-I serum were examined
in parallel using H+ (group O and B) RBCs versus RBCs
from individuals with H-deficient Bombay and para-
Bombay phenotypes.
The logic behind that strategy was based on the
biochemical information showing that the RBC
antigens H-2 (with or without A and B), Ii, and P1 are
constructed upon a common paragloboside precursor
(Fig. 1).33 According to that information,
the deficiency in Bombay and para-
Bombay phenotype RBCs of an α 1,2
fucosyltransferase (FUT1) that catalyzes
fucosylation of the type 2 precursor chain
leads to the absence of the H-2 antigen
(Fucα1,2Galβ1,4GlcNAcβ1,3Galβ1,4Glc-
R), leaving unfucosylated paragloboside
precursor in the crossroads of competing
pathways. The latter include α or β 1,4
galactosylations to produce P1 (Galα1,
4Galβ1,4GlcNAcβ1,3Galβ1,4Glc-R) or I
(1,6-LacNAc bi-antennary branched poly
1,3LacNAc) antigens,respectively. In their
absence, sialylation to sialylparagloboside
may occur.33 The galactophilic lectins
AGL and PA-IL (Tables 1–3) were chosen
because of the major anti-I specificity of
the first17 and P1I (P1 combined with I)
sensitivity of the second.22 Because these
lectins may also interact with T antigen
(Table 1),24 MPL and PNA were added to
the lectin array. Papain treatment of the
RBCs removed the glycoprotein glycans
encompassing the T antigen while
sialidase treatment unmasked that
antigen, enabling PNA and MPL
interactions with T antigen as well as with other RBC
membrane glycoprotein glycans.
Materials and Methods
Lectins and anti-I serum
The lectins used (Table 1) were galactose-binding
AGL,MPL,PNA,and PA-IL and fucose-binding PA-IIL and
UEA-I.MPL,PNA,and UEA-I were purchased from Sigma
(Aldrich, St. Louis, MO). AGL, PA-IL, and PA-IIL were
prepared in our laboratory as previously described.16,20
The anti-I serum (Stephenson) was obtained from Dr.
Marie Cutbush-Crookston (Canada). All lectins and
antiserum were used at a concentration that gave a titer
of 16 units (four positive twofold dilutions) with the
papain- or sialidase-treated group O RBCs (the lectin
concentration being around 5 µg/mL).
Human RBCs
Human RBCs from adults were obtained from the
National Blood Group Reference Laboratory (NBGRL)
at Magen David Adom (MDA) National Blood Services,
Ramat-Gan, Israel. The RBCs were separated by
centrifugation and washed three times with
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Fig. 1. Schematic presentation of the ABO, Ii, P1, Pk, and T antigen structures and
interrelationships (adapted from Moulds et al.33).
Fuc = L-fucose; Gal = D-galactose; GalNAc = N-acetyl-D-galactosamine; Glc = D-glucose;
GlcNAc = N-acetyl-D-glucosamine; SA = sialic acid.
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phosphate-buffered isotonic NaCl solution (PBS).
Samples included RBCs from group O, group B,
Bombay, and para-Bombay phenotype individuals (all
possessing I and P system antigens). RBC samples from
individuals of the Bombay and para-Bombay
phenotypes were obtained from MDA blood donors or
through SCARF contributions.
Papain-treated RBCs were prepared as previously
described20 and sialidase-treated RBCs were similarly
prepared by incubating the washed 5% RBC
suspension in PBS with 0.025 U/mL  sialidase (of Vibrio
cholerae, Behring Diagnostics GmbH, Marburg,
Germany).
Hemagglutination tests
The washed papain- or sialidase- treated RBCs were
suspended in PBS to 5% (v/v) concentration. A volume
of 0.05 mL of these suspensions was added to a series
of tubes containing 0.05 mL of twofold dilutions of the
lectin or antiserum preparations in PBS. The
hemagglutinating activities were examined after a 30-
minute incubation at room temperature and a 30-
second centrifugation.
The diverse hemagglutinins were calibrated to an
agglutination titer of 16 toward the group O (H+)
RBCs. For MPL, PNA, and anti-I serum, sialidase-treated
group O, group B, and Bombay phenotype RBCs were
used, while UEA-I, PA-IIL, PA-IL, and AGL were assayed
with papain-treated group O, group B, Bombay, and
para-Bombay phenotype RBCs.
Results
Agglutination of the group O, group B, Bombay, and
para-Bombay phenotype RBCs by the chosen lectins
and anti-I yielded a very clear-cut segregation of the
applied hemagglutinins into three groups (Fig. 2). As
seen in Figure 2A, the first group included UEA-I and
PA-IIL, which, because of fucose-binding, preferentially
agglutinated the H+ RBCs. UEA-I differed from PA-IIL in
displaying lower activity toward group B RBCs. The
second group included the galactophilic lectins MPL
and PNA, which agglutinated H+ and H– RBCs with no
significant distinction between them (Fig. 2B). The
third group, comprising AGL, PA-IL, and anti-I serum, as
opposed to the previous two groups, most strongly
agglutinated the H-deficient RBCs (Fig. 2A). PA-IL
agglutinated them more strongly than did AGL and
both lectins did so more strongly than did the anti-I.
Figure 2A shows that PA-IL agglutinating activity
toward the group B RBCs was also slightly stronger
Table 1. Lectin characteristics
Carbohydrate Antigen 
Abbreviation Source binding detection References
AGL Aplysia GalUA>Gal I,T, (P1, Pk)* 16,17,24,25,26
gonad
MPL Maclura Gal, GalNAc T plus† 15,27
pomifera
PA-IL Pseudomonas Gal, GalNAc PI‡, BI, (T)* 18,20,22,26,29
aeruginosa
PA-IIL Pseudomonas Fuc>Man Lea, Lex, H-1, H-2 20,22,23
aeruginosa
PNA Arachis Galβ1,3GalNAc T 10,30
hypogaea
UEA-I Ulex Fucα1,2 Gal H-2 8,31
europaeus
* = relatively minor interactions.
† = interactions with T antigen and additional glycotopes.
‡ = P system antigens P1, Pk, P in association with I.7,28
Table 2. Relative sensitivities* of PA-IL and AGL to D-GalNAc and
terminal nonreducing galactose-containing disaccharides, as
compared with D-Gal (=1)25,32
Relative sensitivity
Compound PA-IL AGL
Gal α1,4 Gal 1.8 55
Gal α1,3 Gal 0.8 0.7
D-GalNAc 0.8 0
Gal β1,4 Glc 0.5 0.6
(lactose)
Gal β1,3 GlcNAc 0.4 9.2
(type 1 precursor)
Gal β1,4 GlcNAc 0.2 0.5
(type 2 precursor)
Gal β1,3 GalNAc 0.1 2
*The relative sensitivities were previously obtained using microtiter plate enzyme-
linked lectino-sorbent assay (ELLSA) and inhibition of lectin-glycan binding.25,32
Table 3. Relative sensitivities* of PA-IL and AGL to galactosylated human
blood group B, Ii, P1, and T active glycoproteins† as compared to
D-Gal (=1)25,32
Glycoprotein Blood group Relative sensitivity
(gps) specificity PA-IL AGL




Human ovarian Ii 1.99 2.4
cyst Tighe P-1
glycoprotein
Sheep hydatid P1 3 1.7
cyst glycoprotein
Asialo fetuin I,T 0.11 0.97
*For details see Table 2 footnote.
†The description of the preparation of the cyst fluid blood group active
glycoproteins (by pepsin digestion, precipitation with ethanol, and extraction with
phenol) as well as their proposed carbohydrate side chain structures that display B,
Ii, P1, and T blood group activities are presented in the previous studies.25,32
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than that of AGL. The stronger agglutination of group
B RBCs than of group O RBCs by PA-IL did not
approach that of the H-deficient RBCs. Reactions with
AGL and PA-IL, both of which strongly agglutinated the
H-deficient RBCs (PA-IL more than AGL), and with the
fucose-binding lectins, which negligibly agglutinated
those RBCs, did not differentiate between the Bombay
and para-Bombay phenotype RBCs.
Discussion
The diverse H antigen types are formed by the β-
galactoside α1,2 fucosyltransferases, FUT1 and FUT2,
which are encoded by the H and Se structural genes,
respectively.34,35 They have in common a nonreducing
terminal Fucα1,2Gal β-linked to an oligosaccharide
chain. The differences between them are in the
saccharide preceding the subterminal galactose, which
may be GlcNAc or GalNAc, and the galactose linkage to
it (α/β or 3/4).36 The very rare Bombay9 and para-
Bombay35 phenotypes issue from mutations affecting
either FUT1 (H)37,38 and FUT2 (Se)39 or the genes that
govern the metabolic pathways supplying FUT1 and
FUT2 substrates or coenzymes (especially guanosine 5'-
diphosphate [GDP]-fucose).40,41 The H-encoded FUT1
mainly catalyzes the production of the H type 2 (H-2)
antigen on human RBCs, vascular endothelium, and
other cells of mesodermal origin, while the Se-encoded
FUT2 is expressed in tissues of endodermal origin,
including the exocrine secretion system,42–44
contributing to presence of type 1 and other H
epitopes in secretions of “secretors” (80% of the White
population). Bombay phenotype is defined by total
lack of H epitopes on the RBCs and in secretions (hh,
nonsecretors) associated with the existence of anti-H,
-A, and -B in the serum. In para-Bombay individuals,
there might be detectable heterogeneous traces of H
epitopes on the RBC due to very low transferase
activities. Their serum can also contain some anti-A, -B,
or -H.
Lectins exhibiting α1,2 fucose affinity are useful for
H antigen detection and for Bombay or para-Bombay-
phenotype identification, characterized by no or very
weak agglutination. The most widely used lectin for
this goal is that of the plant U. europaeus,8 which is
highly specific for α1,2 fucose of H-2. This lectin is
most efficient for H epitope detection on human RBCs
and in secretions. It strongly agglutinates human group
O RBCs, in which the α1,2 fucose is fully exposed,with
significant decrease of its hemagglutinating activities
with B, A, and AB RBCs. The reason for the weaker
agglutination of the latter is the stearic hindrance
exerted by the added α1,3Gal (of B), α1,3GalNAc (of
A), or both (in AB) in the vicinity of the H antigen α1,2
fucose (Fig. 1). There are several additional fucose-
binding anti-H lectins from plants, animals, and bacteria
that also agglutinate group O RBCs more strongly than
Fig. 2A. Hemagglutination of papain-treated human group O (horizontal lines); group B (diagonal lines), Bombay (blank bars), and para-Bombay (dotted
bars) RBCs by UEA-I, by fucose-binding PA-IIL and galactophilic PA-IL lectins, and by AGL.
Fig. 2B. Hemagglutination of sialidase-treated human group O (horizontal lines), group B (diagonal lines), and Bombay (blank bars) RBCs by MPL, PNA, and
human anti-I serum.
The data represent means + SEM of five experimental results obtained with seven group O, B, and Bombay, and two different para-Bombay RBC
samples.The asterisks denote significant differences (p < 0.05) in the hemagglutinating activities toward group B, Bombay, or para-Bombay versus
group O RBCs.
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Bombay and para-Bombay phenotype RBCs. Those
lectins differ from UEA-I in their affinities to the
saccharides and their discrimination range for subtle
variations as well as in their sensitivities to the H
antigen phenotypes and to interferences by the B and
A epitopes.5–7 One of them is the bacterial fucose-
binding lectin PA-IIL (Table 1) isolated from the
opportunistic pathogen P. aeruginosa.20 This lectin
displays the highest fucose affinity (µmolar level)21,23
resembling that of antibodies rather than lectins,
including UEA-I. Unlike that of UEA-I, its reaction with
the α1,2 fucosyl of the H antigen is neither restricted
to H-222,23 nor significantly interfered with by the
neighboring galactose (of B) or GalNAc (of A). Its
reactions with H type 1 (H-1) and Le glycotopes are
stronger than those with H-2 antigen,23 and those with
group B (Fig. 2A) and group A RBCs are only slightly
weaker than with group O RBCs.22 The very weak
agglutination of Bombay phenotype RBCs by PA-IIL
might be attributed to the Lea molecules that are
adsorbed onto them.4,7 The latter, which are not
detected by UEA-I, attract PA-IIL.23
In individuals of the Bombay and para-Bombay
phenotypes with mutated FUT1, the type 2 precursor
that terminates in Galβ1,4GlcNAc (LacNAc) is not
fucosylated. Eventually its location at the crossroads of
additional antigen syntheses exposes it to competing
glycosyltransferases that might add either α1,4
galactose or poly LacNAc (including branching),
leading to increased formation of P1 and I antigens,
respectively (Fig.1). These considerations led us to
examine the interactions of H-deficient RBCs with
galactose-binding lectins that interact with Ii, P system,
and T antigens, as well as with the nonfucosylated
types 1 and 2 precursors (Table 2), all of which contain
terminal galactose β or α (1,3 or 1,4)-linked to GlcNAc,
Gal, or GalNAc. Among the lectins used, MPA and PNA
bind to human RBCs galactosylated glycoprotein O-
glycans;AGL binds both to the glycoproteins and to the
glycolipids; and PA-IL,mainly to the latter. Desialylation
of the RBCs (for unmasking the Galβ1,3GalNAc of the
glycoprotein-bound T antigen) enabled MPA and PNA
interactions. Papain treatment facilitated AGL and PA-IL
interactions with the RBC glycolipid Ii and P system
antigens and type 2 precursor.
The data presented in Figure 2 show that the
fucose-specific H-binding lectins UEA-I and PA-IIL (the
first mainly H-2 specific and the second exhibiting a
wider reactivity spectrum) strongly agglutinated the
H+ group O RBCs while negligibly agglutinating the H-
deficient Bombay and para-Bombay RBCs (Fig.2A). The
galactophilic anti-T lectins MPL and PNA did not
differentiate between the group O and Bombay
phenotype RBCs (Fig.2B). In contrast, the galactophilic
anti-I serum and P1 lectins AGL and PA-IL, which
weakly bind to the type 2 precursor (Table 2),25,26,29,32
resembled anti-I in agglutinating the H-deficient RBCs
of the two types significantly more strongly than they
did the H+ group O RBCs (Fig. 2A).
Previous studies using B, Ii, and P1 blood group
active glycoproteins isolated from human ovarian cyst
and sheep hydatid cyst showed AGL preference of I
over P1 (Table 3).25 In addition, our previous data
demonstrated that pp (Tj[a–])RBCs45 were agglutinated
by AGL, as well as by anti-I , more strongly than were
P1+ RBCs.26 Therefore it may be suggested that the
stronger agglutination of H-deficient RBCS by AGL is
because of elevated I antigenicity on those RBCs.
In addition, our previous findings showed PA-IL
having the highest affinity to P1I combination29 (the
existence of that complex had been described by
several investigators46–48), but neither to I nor to P1
alone. The later finding was based on the observations
that PA-IL weakly agglutinated not only P1+ I-deficient
RBCs (like AGL and anti-I), but (unlike them) also the I-
rich pp RBCs.26,29 Hence, its stronger agglutination of
the H-deficient RBCs indicates that there is a
concomitant increase in P1 and I antigen levels on
them.
It may be concluded that the parallel use of the
galactophilic lectins AGL and PA-IL efficiently
demonstrated that the nonfucosylated type-2
precursor, located at the central crossroads of the
syntheses of human RBC ABO, P1, and Ii antigens
(Fig.1), is used for concomitantly increased formation
of both I and P1 antigens on the H-deficient Bombay
and para-Bombay RBCs.
Because PA-IL and PA-IIL might serve the pathogen
in adhesion to human RBCs via their galactosylated P1I
and BI antigen combinations or their H or Lewis
antigens, respectively,22,23,49 it would be interesting to
compare the prevalence of P. aeruginosa infections in
H+ and H-deficient populations. Results of such a study
might provide some indirect information as to the
relative contribution of PA-IL and PA-IIL to this
bacterium infectivity.
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